Coexpression of PD-L1/PD-1 with CXCR3/CD36 and IL-19 Increase in Extranodal Lymphoma

Table 1

Extranodal involvement sites in 34 lymphoma patients.

		Patients with lymphoma
		Extranodal involvement	No	44 (56.4%)
Yes	34 (43.6%)
Central nervous system	No	77 (98.7%)
	Yes	1 (1.3%)
Bone marrow	No	52 (66.7%)
	Yes	26 (33.3%)
Lymph vessels	No	61 (78.2%)
	Yes	17 (21.8%)
Intestine	No	77 (98.7%)
	Yes	1 (1.3%)
Lung	No	68 (87.2%)
	Yes	10 (12.8%)
Liver	No	71 (91%)
	Yes	7 (9%)
Thyroid	No	77 (98.7%)
	Yes	1 (1.3%)
Spleen	No	70 (89.7%)
	Yes	8 (10.3%)